Field Trip Health Ltd (FTRP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FTRP | ZTS | TAK | NBIX | UTHR |
| Company | Field Trip Health Ltd | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 4.2000 | 158.42 | 13.15 | 136.05 | 234.76 |
| High | 4.2505 | 165.04 | 13.19 | 139.37 | 240.93 |
| Low | 4.0705 | 158.42 | 13.11 | 136.05 | 234.76 |
| Last | 4.2105 | 159.76 | 13.17 | 138.27 | 238.36 |
| Change | +0.0445 | +1.34 | +0.14 | +2.28 | +4.51 |
| % Change | +1.07% | +0.85% | +1.07% | +1.68% | +1.93% |
| Volume | 32,880 | 3,758,022 | 1,079,516 | 447,306 | 262,709 |
| 20-Day Average Volume | 156,550 | 4,361,016 | 1,742,495 | 735,529 | 463,731 |
| Previous Close | 4.1660 | 158.42 | 13.03 | 135.99 | 233.85 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8423 | 157.01 | 13.36 | 136.35 | 235.00 |
| 20-Day Raw Stochastic | 31.74% | 61.83% | 18.77% | 59.92% | 83.08% |
| 20-Day Relative Strength | 48.87% | 45.45% | 36.89% | 53.79% | 54.44% |
| Weighted Alpha | -82.40 | -16.54 | -21.95 | +42.80 | +11.39 |
| Today's Opinion | 72% Sell | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Previous Opinion | 72% Sell | 72% Sell | 100% Sell | 48% Buy | 64% Buy |
| Last Month's Opinion | 72% Sell | 40% Sell | 72% Sell | 88% Buy | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.93% since 08/09/22 | +9.94% since 04/22/24 | -1.58% since 04/22/24 | +4.03% since 04/22/24 | +1.98% since 04/22/24 |
| Low | 0.8101 on 08/15/22 | 145.18 on 04/23/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 0.8650 on 08/12/22 | 165.04 on 04/29/24 | 13.41 on 04/23/24 | 145.00 on 04/23/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | +0.26% since 07/15/22 | -5.44% since 03/28/24 | -5.33% since 03/28/24 | +0.81% since 03/28/24 | +3.91% since 03/28/24 |
| Low | 0.7803 on 08/02/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 0.9750 on 07/20/22 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | -9.78% since 05/16/22 | -16.99% since 01/29/24 | -10.97% since 01/29/24 | -2.24% since 01/29/24 | +10.05% since 01/29/24 |
| Low | 0.7400 on 06/23/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 0.9950 on 05/18/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | -47.04% since 02/16/22 | +2.55% since 10/27/23 | -2.38% since 10/27/23 | +31.08% since 10/27/23 | +8.88% since 10/27/23 |
| Low | 0.7100 on 05/10/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 1.7400 on 03/21/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 49,023 | 72,454,816 | 41,237,580 | 13,531,958 | 11,004,745 |
| Shares Outstanding, K | 58,215 | 457,359 | 3,164,818 | 99,507 | 47,059 |
| Annual Sales | 3,880,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -43,630,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 1,370,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -11,210,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | N/A | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 06/29/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 08/15/22 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.83 | 6.70 | 56.93 | 11.89 |